A new AGA guideline provides direction to GIs and their inflammatory bowel syndrome patients when trying to identify an effective drug therapy. The guideline and accompanying technical review are published in the November issue of Gastroenterology.
The new guideline was developed using GRADE methodology. AGA conducted a rigorous, evidenced-based review of the extensive body of literature on describing pharmacologic therapy for IBS. Review of this guideline plus the associated technical review will, it is hoped, promote effective shared decision making with patients for this common, chronic set of symptoms.
To see this guideline, as well as all other AGA guidelines, visit www.gastro.org/guidelines.
